Regnum (Regnum) General and Admin. Expense : $0.65 Mil (TTM As of Mar. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Regnum General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Regnum's General and Admin. Expense for the three months ended in Mar. 2023 was $0.18 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2023 was $0.65 Mil.

Regnum General and Admin. Expense Historical Data

The historical data trend for Regnum's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regnum General and Admin. Expense Chart

Regnum Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

General and Admin. Expense

Get a 7-Day Free Trial

0.02

0.04

0.12

0.37

0.74

Regnum Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
General and Admin. Expense	Get a 7-Day Free Trial															0.28	0.18	0.16	0.13	0.18

Regnum General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.65 Mil.

Regnum General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Regnum's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Regnum (Regnum) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regnum Corp (OTCPK:RGMP) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

600 Third Avenue, 19th Floor, New York, NY, USA, 10016

Website

https://www.regnumcorp.com

Regnum Corp is focused on developing and commercializing therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a CCR5 antagonist to treat multi-drug resistant HIV infection.

Regnum (Regnum) Headlines

No Headlines